Developing a universal vaccine for influenza.

COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTER: CLINICAL CORE

NIH-funded research Duke University · NIH-10655265

This study is working on a new flu vaccine that could protect against many different types of the flu, and if you're interested, you can join the clinical trials to help test how safe and effective it is!

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionDuke University NIH-funded
Lab location1 site (Durham, United States)
Project IDNIH-10655265 on NIH RePORTER

What this research studies

This research focuses on creating a universal influenza vaccine that can provide broader protection against various strains of the flu virus. The approach involves collaboration among multiple centers to innovate and enhance vaccine development processes. Patients may participate in clinical trials to test the safety and effectiveness of new vaccine formulations, contributing to advancements in flu prevention.

Who could benefit from this research

Good fit: Ideal candidates include individuals who are at higher risk for influenza complications, such as the elderly, young children, and those with underlying health conditions.

Not a fit: Patients who are not at risk for influenza or those who have already received a flu vaccine may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to a more effective vaccine that protects against multiple strains of influenza, reducing the incidence of flu-related illnesses.

How similar studies have performed: Previous research has shown promise in developing universal vaccines for influenza, indicating that this approach has potential for success.

Where this research is happening

Durham, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions National Institute of Allergy and Infectious Disease
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.